Skip to search formSkip to main contentSkip to account menu

Amikacin

Known as: O-3-amino-3-Deoxy-alpha-D-glucopyranosyl-(1->4)-O-(6-amino-6-deoxy-alpha-D-glucopyranosyl-(1->6))-N(3)-(4-amino-L-2-hydroxybutyryl)-2-deoxy-L-streptamine, Amikacina, Amicacin 
A broad-spectrum semi-synthetic aminoglycoside antibiotic, derived from kanamycin with antimicrobial property. Amikacin irreversibly binds to the… 
National Institutes of Health

Related topics

Related topics

29 relations

Narrower (7)

3',4'-dideoxyamikacin3'-deoxyamikacinAmikacina NormonAmikin
Amikacin SulfateAmikacin:Susc:Pt:Isolate:OrdQn:Agar diffusionAminoglycosidesBacterial Infections

Broader (1)

Anti-Bacterial Agents

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
In Vitro Efficacy of Cefepime Against Multi-Drug Resistant Pseudomonas aeruginosa – An Alarming Situation in our Setup
Background: Third generation cephalosporins are still most commonly used antibiotics empirically in our setup leading to… 
2007
2007
Bacteremia Caused by Rothia mucilaginosa in a Patient with Shwachman-Diamond Syndrome
Rothia mucilaginosa, previously known as Stomatococcus mucilaginosus, is a Gram-positive microrganism, which is a part of normal… 
Review
1986
Review
1986
Survey of aminoglycoside resistance patterns.
We studied the susceptibility of 545 gram-negative clinical isolates to six aminoglycosides: gentamicin, tobramycin, netilmicin… 
1982
1982
In vitro susceptibility of mycobacteria species other than Mycobacterium tuberculosis to amikacin, cephalosporins and cefoxitin.
The susceptibility of different species of mycobacteria, other than M. tuberculosis, to a range of cephalosporins and to amikacin… 
1977
1977
Comparison of amikacin and tobramycin in the treatment of infection in patients with cancer.
Two new aminoglycoside antibiotics, tobramycin and amikacin, were compared in a randomized study of the treatment of infections… 
1977
1977
Patterns and mechanisms of emergence of resistance to amikacin.
Emergence of gram-negative bacilli resistant to amikacin occurred in five of 96 patients treated. Three of the five instances… 
1976
1976
Amikacin for treatment of infections in patients with malignant diseases.
Amikacin was evaluated in patients with malignant diseases during 134 episodes of identified infection, most of which were cases… 
1976
1976
125I-Radioimmunoassay of amikacin and comparison with a microbioassay.
A radioimmunoassay (RIA) has been developed using 125I-amikacin. Amikacin was iodinated by a modified BOLTON and HUNTER method… 
1976
1976
Pharmacokinetics of amikacin in patients with renal insufficiency: relation of half-life and creatinine clearance.
The half-life of amikacin after a single intramuscular injection was determined in patients with severe renal failure who… 
Highly Cited
1975
Highly Cited
1975
Amikacin therapy of infections in neutropenic patients
Amikacin, a new aminoglycoside antibiotic, was utilized in the treatment of 49 cases of infection which occurred in 39…